Tag: Tagrisso combination therapy

Home / Tagrisso combination therapy

Categories

Osimertinib with chemotherapy is approved by the USFDA for EGFR-mutated non-small cell lung cancer

The Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) in combination with platinum-based chemotherapy for patients with locally advanced or metastatic non-s...
tagrisso-combination-therapy

We Are Online! Chat With Us!
Scan the code